98%
921
2 minutes
20
While surgical resection of pulmonary typical carcinoid is the primary curative treatment, the optimal extent of resection remains debated, with limited data on survival outcomes and prognostic factors guiding management. This study compared surgical resections of typical carcinoids and evaluated survival and recurrence rates. It also seeks to identify negative prognostic factors to improve the management. A single-center retrospective study analyzed data from patients who underwent surgery for typical carcinoid between 1998 and 2023. The surgery was divided into three groups: atypical segmentectomies, typical segmentectomies, and lobectomies. Clinical and pathological characteristics, perioperative outcomes, and survival rates were assessed. The survival curves were generated using the Kaplan-Meier method, and Cox regression analysis identified prognostic factors for overall survival (OS). Of the 524 patients, 187 (35.7%) were typical carcinoid. Among them, 20% underwent atypical segmentectomy, 3% underwent typical segmentectomy, and 77% underwent lobectomy. The 5-year OS rate was 86%. Recurrence was observed in two patients, all in the lobectomies. The number of mitoses (p = 0.026) and nodal metastases (p = 0.0002) were negative prognostic factors for OS. No significant difference between the surgical approaches was found for OS (Log-rank test = 0.48) or disease-free survival (DFS) (Log-rank test = 0.76). While lobectomy remains the most commonly performed procedure for typical carcinoid, none of the evaluated surgical approaches significantly influenced OS or DSF. Notably, mitoses and nodal metastases emerged as key negative prognostic factors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s13304-025-02292-0 | DOI Listing |
Pediatr Blood Cancer
September 2025
Acute Myeloid Leukemia Sub-Committee, Association of Childhood Leukemia Study (JACLS), Japan.
Background: Relapsed or refractory cases of pediatric acute myeloid leukemia (AML) have poor outcomes despite advancements in chemotherapy and hematopoietic stem cell transplantation (HSCT). While a second HSCT is often a salvage option, its outcomes vary widely, and prognostic factors remain unclear.
Objectives: This study aimed to evaluate outcomes and identify prognostic factors in pediatric patients with AML who underwent multiple HSCTs.
Alzheimers Dement
September 2025
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.
Introduction: Risperidone is approved for behaviors and psychological symptoms of dementia (BPSD), despite modest efficacy and known risks. Identifying responsive symptoms, treatment modifiers, and predictors is crucial for personalized treatment.
Method: A one-stage individual participant data meta-analysis of six randomized controlled trials (risperidone: n = 1009; placebo: N = 712) was conducted.
Diagn Progn Res
September 2025
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Background: Hospital-acquired venous thromboembolism (HA-VTE) is a leading cause of morbidity and mortality among hospitalized adults. Numerous prognostic models have been developed to identify those patients with elevated risk of HA-VTE. None, however, has met the necessary criteria to guide clinical decision-making.
View Article and Find Full Text PDFJ Egypt Natl Canc Inst
September 2025
National Cancer Institute of Cairo University, Giza, Egypt.
Objectives: To balance the extended functional urinary voiding and morbidity outcomes amid Ileal W and Y-shaped contrasted to spherical ileocoecal (IC) orthotopic bladders subsequent prostate-sparing radical cystectomy (PRC) versus standard radical cystoprostatectomy (RC).
Material And Methods: Two hundred eight male bladder cancer patients were grouped into 98 RC followed by 43-W, 31-Y, and 23-IC in comparison to 110 PRC followed by 35-W, 37-Y, and 38-IC. The functional voiding outcomes were determined by detailed patients' interview and urodynamic studies (UDS).
Pediatr Nephrol
September 2025
Department of Clinical Laboratory, Medical School, South China Hospital, Shenzhen University, Shenzhen, Guangdong, China.